Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE
Go back to Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.47 +0.60 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.87 | 52 Week High | $108.63 | |||
| Open | $126.63 | 52 Week Low | $71.39 | |||
| Day High | $126.63 | P/E | 69.32 | |||
| Day Low | $124.44 | EPS | $1.81 | |||
| Volume | 2,346,510 | |||||
| StemCells, Inc. (NASDAQ: TEM) | Delayed: 49.60 +1.75 (3.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.85 | 52 Week High | $0.45 | |||
| Open | $47.00 | 52 Week Low | $0.37 | |||
| Day High | $49.85 | P/E | N/A | |||
| Day Low | $46.68 | EPS | $-0.31 | |||
| Volume | 2,332,423 | |||||
